General Information


DRAVP ID  DRAVPe01088

Peptide Name   13(derived from HCV C5A)

Sequence  CEVLSDFK

Sequence Length  8

UniProt ID  P26664 

Source  Synthetic construct(derived from HCV non-structural protein 5A)



Activity Information


Target Organism  HCV

Assay  RT-QPCR assay

Activity 

  • [Ref.18287023]Hepatitis C virus(HCV):inhibition of HCV infection in Huh-7.5.1 cells(IC50>27 μM).

Hemolytic Activity  No hemolysis information or data found in the reference(s) presented in this entry

Cytotoxicity  No cytotoxicity information found in the reference(s) presented

Binding Target  membrane

Mechanism  The peptide destabilizes viral structural integrity and has viral membranolytic activity.It interacts with the viral membrane to disrupt its integrity, release viral capsids, and expose the viral genome to exonucleases for degradation.



Structure Information


PDB ID  None

Predicted Structure Download  DRAVPe01088

Linear/Cyclic  Linear

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Stereochemistry  L



Physicochemical Information


Formula  C41H65N9O14S

Absent amino acids  AGHIMNPQRTWY

Common amino acids  CDEFKLSV

Mass  940.08

Pl  4.37

Basic residues  1

Acidic residues  2

Hydrophobic residues  3

Net charge  -1

Boman Index  -1126

Hydrophobicity  20

Aliphatic Index  85

Half Life 

  •     Mammalian:1.2 hour
  •     Yeast:>20 hour
  •     E.coli:>10 hour

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  2



Literature Information


Literature 1

Title   A virocidal amphipathic {alpha}-helical peptide that inhibits hepatitis C virus infection in vitro.

Pubmed ID   18287023

Reference   Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):3088-93.

Author   Cheng G, Montero A, Gastaminza P, Whitten-Bauer C, Wieland SF, Isogawa M, Fredericksen B, Selvarajah S, Gallay PA, Ghadiri MR, Chisari FV.

DOI   10.1073/pnas.0712380105